-
3740 E Southern Ave, Ste 210
Mesa, AZ 85206 -
Monday–Friday, 9:00 AM – 6:00 PM MST
by appointment only -
Saturday
By Appointment -
Sunday
Closed
Spravato treatment duration is one of the first things adults ask about when they hear of this option. Spravato is a nasal spray made from esketamine, and it is given in a medical office on a set schedule. The honest answer to “how long?” is that it differs from person to person.
This guide explains how the schedule is built, how providers decide what comes next, and why staying consistent matters. You can also see how treatment-resistant depression care in Mesa is organized locally. Knowing the general pattern helps you plan work, family time, and rides to your visits.
People often hope for a clear end date. In practice, depression treatment rarely works that way. Each person starts from a different place and responds at a different pace. Spravato treatment duration reflects that range.
According to the National Alliance on Mental Illness (NAMI), no fixed length is given for esketamine treatment. The provider decides how long it continues, together with the patient. The same page says timing and frequency may change over the weeks.
This is why general numbers should be treated as a starting guide. Two people can begin on the same day and have very different schedules a few months later. Spravato treatment duration is shaped by how each person responds, not by a calendar alone. Asking your provider how your own plan will be reviewed is a useful first step.
Treatment starts with a more frequent schedule and then slows down. According to MedlinePlus, adults with treatment-resistant depression usually receive doses twice a week during weeks 1 to 4. The schedule then moves to once a week during weeks 5 to 8. From week 9 onward, doses are given weekly or every two weeks.
The same page explains that your doctor monitors you before each dose, during treatment, and for at least 2 hours afterward. Each visit therefore includes both the dose and the observation time. Our page on Spravato treatment for treatment-resistant depression explains how this care is evaluated and delivered.
The first four weeks are often called the induction phase. This is the starting phase, when doses are closest together. After it, treatment moves into the maintenance phase, which aims to keep symptoms under control.
According to the drug label on DailyMed, approved by the U.S. Food and Drug Administration (FDA), the benefit of treatment is assessed at the end of the four-week induction phase. That review helps decide whether treatment should continue. The label also says dosing frequency should be individualized to the least frequent dosing that maintains remission or response. Remission means symptoms have mostly cleared, and response means they have clearly improved.
Regular follow-up is part of good care. Our page on psychiatric evaluations and medication management explains how providers review your history and adjust plans over time.
Once visits become less frequent, many people expect them to feel different. In most ways, they are the same. You still arrive on time, receive a dose in the clinic, and stay for monitoring. You also still need a safe ride home.
You can read what a visit involves in our article on what patients can expect during a Spravato session. Fewer visits do not mean less attention. Your provider continues to ask how you are sleeping, eating, working, and feeling.
It also helps to plan the practical side. Arrange rides ahead of time, and block out enough hours around each visit so you are not rushed. A predictable routine makes longer-term treatment easier to keep up.
Short notes give your provider a clearer picture than memory alone. They can also show patterns, such as a low mood that appears near the end of each week. That detail can guide decisions about timing.
It is common to feel better and wonder whether treatment is still needed. The NAMI page gives a clear message on this point. It says not to stop taking esketamine, even when you feel better. Any change should be discussed with your provider first.
The same source also says missing doses may increase your risk of relapse. Relapse means depression symptoms come back after a period of improvement. If you miss a session and symptoms worsen, the page advises telling your provider right away. Do not wait for the next scheduled visit to raise the concern.
A steady routine gives your provider reliable information. It also makes it easier to tell whether a change in mood comes from the treatment, from stress, or from something else.
No two plans look the same. Several factors can influence how long treatment continues and how often visits happen.
Your provider looks at all of these together when reviewing Spravato treatment duration. No single factor decides the plan, and the mix can shift as your life or health changes. A review that happens on a regular basis keeps the plan matched to where you are now.
Practical barriers matter more than people expect. If getting to visits becomes hard, tell your provider early. Together you can look for solutions before a gap in treatment happens.
Treatment plans can change over time. A provider may space visits further apart, adjust the plan, or discuss other options. This is a medical decision, and it should be made with your provider and not alone.
The same NAMI page says patients should be monitored for symptoms of dependence after esketamine treatment has ended. Dependence means the body or mind relies on a drug and reacts when the dose is lowered or stopped. Watching for these symptoms is part of safe follow-up. This is one reason to plan any change in advance.
Ask what to expect in the days and weeks after a change. Knowing which symptoms to watch for, and who to contact, makes the transition less stressful. Family members or close friends can also help by noticing shifts in mood or sleep that you may miss yourself.
You can read more about what you might feel in our article on Spravato side effects.
No end date is set in advance. Your provider decides how long treatment continues, together with you.
No. The schedule usually starts with more frequent visits and then becomes less frequent. Your provider can adjust it based on how you respond.
It depends on your symptoms, your health, how you tolerate treatment, and your goals. Regular reviews help guide decisions.
Do not stop on your own. NAMI advises not to stop even when you feel better. Talk with your provider about any change first.
Contact the treatment office as soon as you can. If your symptoms worsen, tell your provider right away.
Yes. Many people worry about what comes next. Asking your provider for a clear plan, and for regular check-ins, can ease that worry.
Treatment length is not a test of how well you are doing. It is a plan that adjusts as your needs change. Some people move to fewer visits over time, while others need a steady schedule for longer.
Bring your questions to every visit, and keep short notes between appointments. Understanding Spravato treatment duration helps you plan ahead for work, family life, and travel. It also helps you feel more involved in each decision that comes next.
Disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Treatment length and schedules are decided by a qualified provider based on your individual needs. If you are in crisis or having thoughts of harming yourself, contact your local emergency services or a crisis line right away.